NADH, the reduced form of NAD+, has been clinically utilized since the 1980s for treating conditions such as Parkinson’s disease, Alzheimer’s disease, chronic fatigue syndrome, and depression, offering relief and improving patients' quality of life. Recent research indicates that NADH is an effective alternative for boosting NAD+ levels, alongside well-known precursors like NMN and NR. Unique among NAD+ enhancers, NADH directly contributes to ATP production by participating in the electron transport chain, making it highly effective in improving cellular energy. Additionally, NADH exhibits a superior ability to cross cell membranes compared to other NAD+ boosters, which are in an oxidized form and more susceptible to degradation by CD38, an enzyme that targets oxidized NAD+ precursors.
 
However, NADH-based products are less common in the market due to the challenge of stabilizing the active NADH compound, which is sensitive to light, moisture, oxygen, and high temperatures. Addressing this issue, CELFULL has developed the Turn A® NADH microspheres, enhancing both the stability and bioavailability of NADH significantly.
 
The Turn A® NADH microspheres have been incorporated into CELFULL's Frozen Youth product. For more information about this product, please refer to [product link]